Diminished postprandial secretion of incretins and insulin represents one of the key pathophysiological mechanisms behind type 2 diabetes (T2D). We tested the effects of two energy- and macronutrient-matched meals: A standard meat (M-meal) and a vegan (V-meal) on postprandial incretin and insulin secretion in participants with T2D. A randomized crossover design was used in 20 participants with T2D. Plasma concentrations of glucose, insulin, C-peptide, glucagon-like peptide-1 (GLP-1), amylin, and gastric inhibitory peptide (GIP) were determined at 0, 30, 60, 120, and 180 min. Beta-cell function was assessed with a mathematical model, using C-peptide deconvolution. Repeated-measures ANOVA was used for statistical analysis. Postprandial plasma glucose responses were similar after both test meals (p = 0.64). An increase in the stimulated secretion of insulin (by 30.5%; 95% CI 21.2 to 40.7%; p < 0.001), C-peptide (by 7.1%; 95% CI 4.1 to 9.9%; p < 0.001), and amylin (by 15.7%; 95% CI 11.8 to 19.7%; p < 0.001) was observed following consumption of the V-meal. An increase in stimulated secretion of GLP-1 (by 19.2%; 95% CI 12.4 to 26.7%; p < 0.001) and a decrease in GIP (by -9.4%; 95% CI -17.3 to -0.7%; p = 0.02) were observed after the V-meal. Several parameters of beta-cell function increased after the V-meal, particularly insulin secretion at a fixed glucose value 5 mmol/L, rate sensitivity, and the potentiation factor. Our results showed an increase in postprandial incretin and insulin secretion, after consumption of a V-meal, suggesting a therapeutic potential of plant-based meals for improving beta-cell function in T2D.

Institute for Clinical and Experimental Medicine 14021 Prague Czech Republic

Institute of Endocrinology 11394 Prague Czech Republic

Metabolic Unit CNR Institute of Neuroscience 35127 Padua Italy

Physicians Committee for Responsible Medicine Washington 5100 Wisconsin Ave NW Suite 400 Washington DC 20016 USA

Zobrazit více v PubMed

Feskens E.J., Virtanen S.M., Räsänen L., Tuomilehto J., Stengård J., Pekkanen J., Nissinen A., Kromhout D. Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care. 1995;18:1104–1112. doi: 10.2337/diacare.18.8.1104. PubMed DOI

Fizelova M., Jauhiainen R., Stančáková A., Kuusisto J., Laakso M. Finnish Diabetes Risk Score Is Associated with Impaired Insulin Secretion and Insulin Sensitivity, Drug-Treated Hypertension and Cardiovascular Disease: A Follow-Up Study of the METSIM Cohort. PLoS ONE. 2016;11:e0166584. doi: 10.1371/journal.pone.0166584. PubMed DOI PMC

Mann J.I., De Leeuw I., Hermansen K., Karamanos B., Karlström B., Katsilambros N., Riccardi G., Rivellese A.A., Rizkalla S., Slama G., et al. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr. Metab. Cardiovasc. Dis. 2004;14:373–394. doi: 10.1016/S0939-4753(04)80028-0. PubMed DOI

Perry B., Wang Y. Appetite regulation and weight control: The role of gut hormones. Nutr. Diabetes. 2012;2:e26. doi: 10.1038/nutd.2011.21. PubMed DOI PMC

Meier J.J. The contribution of incretin hormones to the pathogenesis of type 2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 2009;23:433–441. doi: 10.1016/j.beem.2009.03.007. PubMed DOI

Verdich C., Flint A., Gutzwiller J.P., Näslund E., Beglinger C., Hellström P.M., Long S.J., Morgan L.M., Holst J.J., Astrup A. A meta-analysis of the effect of glucagon-like peptide-1 (7–36) amide on ad libitum energy intake in humans. J. Clin. Endocrinol. Metab. 2001;86:4382–4389. doi: 10.1210/jc.86.9.4382. PubMed DOI

Lutz T.A. The interaction of amylin with other hormones in the control of eating. Diabetes Obes. Metab. 2013;15:99–111. doi: 10.1111/j.1463-1326.2012.01670.x. PubMed DOI

Belinova L., Kahleova H., Malinska H., Topolcan O., Vrzalova J., Oliyarnyk O., Kazdova L., Hill M., Pelikanova T. Differential acute postprandial effects of processed meat and isocaloric vegan meals on the gastrointestinal hormone response in subjects suffering from type 2 diabetes and healthy controls: A randomized crossover study. PLoS ONE. 2014;9:e107561. doi: 10.1371/journal.pone.0107561. PubMed DOI PMC

Aune D., Ursin G., Veierød M.B. Meat consumption and the risk of type 2 diabetes: A systematic review and meta-analysis of cohort studies. Diabetologia. 2009;52:2277–2287. doi: 10.1007/s00125-009-1481-x. PubMed DOI

Pan A., Sun Q., Bernstein A.M., Schulze M.B., Manson J.E., Willett W.C., Hu F.B. Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. Am. J. Clin. Nutr. 2011;94:1088–1096. doi: 10.3945/ajcn.111.018978. PubMed DOI PMC

Vang A., Singh P.N., Lee J.W., Haddad E.H., Brinegar C.H. Meats, processed meats, obesity, weight gain and occurrence of diabetes among adults: Findings from Adventist Health Studies. Ann. Nutr. Metab. 2008;52:96–104. doi: 10.1159/000121365. PubMed DOI

Maron D.J., Fair J.M., Haskell W.L. Saturated fat intake and insulin resistance in men with coronary artery disease. The Stanford Coronary Risk Intervention Project Investigators and Staff. Circulation. 1991;84:2020–2027. doi: 10.1161/01.CIR.84.5.2020. PubMed DOI

Zong G., Li Y., Wanders A.J., Alssema M., Zock P.L., Willett W.C., Hu F.B., Sun Q. Intake of individual saturated fatty acids and risk of coronary heart disease in US men and women: Two prospective longitudinal cohort studies. BMJ. 2016;355:i5796. doi: 10.1136/bmj.i5796. PubMed DOI PMC

Tonstad S., Butler T., Yan R., Fraser G.E. Type of Vegetarian Diet, Body Weight, and Prevalence of Type 2 Diabetes. Diabetes Care. 2009;32:791–796. doi: 10.2337/dc08-1886. PubMed DOI PMC

Kahleova H., Matoulek M., Malinska H., Oliyarnik O., Kazdova L., Neskudla T., Skoch A., Hajek M., Hill M., Kahle M., et al. Vegetarian diet improves insulin resistance and oxidative stress markers more than conventional diet in subjects with Type 2 diabetes. Diabetes Med. 2011;28:549–559. doi: 10.1111/j.1464-5491.2010.03209.x. PubMed DOI PMC

Barnard N.D., Cohen J., Jenkins D.J.A., Turner-McGrievy G., Gloede L., Jaster B., Seidl K., Green A.A., Talpers S. A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care. 2006;29:1777–1783. doi: 10.2337/dc06-0606. PubMed DOI

Van Cauter E., Mestrez F., Sturis J., Polonsky K.S. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992;41:368–377. doi: 10.2337/diabetes.41.3.368. PubMed DOI

Mari A., Tura A., Gastaldelli A., Ferrannini E. Assessing insulin secretion by modeling in multiple-meal tests: Role of potentiation. Diabetes. 2002;51(Suppl. 1):S221–S226. doi: 10.2337/diabetes.51.2007.S221. PubMed DOI

Mari A., Schmitz O., Gastaldelli A., Oestergaard T., Nyholm B., Ferrannini E. Meal and oral glucose tests for assessment of beta-cell function: Modeling analysis in normal subjects. Am. J. Physiol. Endocrinol. Metab. 2002;283:E1159–E1166. doi: 10.1152/ajpendo.00093.2002. PubMed DOI

Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. doi: 10.1007/BF00280883. PubMed DOI

Tura A., Chemello G., Szendroedi J., Göbl C., Færch K., Vrbíková J., Pacini G., Ferrannini E., Roden M. Prediction of clamp-derived insulin sensitivity from the oral glucose insulin sensitivity index. Diabetologia. 2018;61:1135–1141. doi: 10.1007/s00125-018-4568-4. PubMed DOI

Ismail-Beigi F. Clinical practice. Glycemic management of type 2 diabetes mellitus. N. Engl. J. Med. 2012;366:1319–1327. doi: 10.1056/NEJMcp1013127. PubMed DOI

Page K.A., Reisman T. Interventions to Preserve Beta-Cell Function in the Management and Prevention of Type 2 Diabetes. Curr. Diabetes Rep. 2013;13:252–260. doi: 10.1007/s11892-013-0363-2. PubMed DOI PMC

Kahleova H., Tura A., Hill M., Holubkov R., Barnard N.D. A Plant-Based Dietary Intervention Improves Beta-Cell Function and Insulin Resistance in Overweight Adults: A 16-Week Randomized Clinical Trial. Nutrients. 2018;10:189. doi: 10.3390/nu10020189. PubMed DOI PMC

Nauck M.A., Homberger E., Siegel E.G., Allen R.C., Eaton R.P., Ebert R., Creutzfeldt W. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J. Clin. Endocrinol. Metab. 1986;63:492–498. doi: 10.1210/jcem-63-2-492. PubMed DOI

Knop F.K., Vilsbøll T., Højberg P.V., Larsen S., Madsbad S., Vølund A., Holst J.J., Krarup T. Reduced incretin effect in type 2 diabetes: Cause or consequence of the diabetic state? Diabetes. 2007;56:1951–1959. doi: 10.2337/db07-0100. PubMed DOI

Calanna S., Christensen M., Holst J.J., Laferrère B., Gluud L.L., Vilsbøll T., Knop F.K. Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: Systematic review and meta-analysis of clinical studies. Diabetes Care. 2013;36:3346–3352. doi: 10.2337/dc13-0465. PubMed DOI PMC

Kjems L.L., Holst J.J., Vølund A., Madsbad S. The influence of GLP-1 on glucose-stimulated insulin secretion: Effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Diabetes. 2003;52:380–386. doi: 10.2337/diabetes.52.2.380. PubMed DOI

Kang Z.F., Deng Y., Zhou Y., Fan R.R., Chan J.C.N., Laybutt D.R., Luzuriaga J., Xu G. Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes. Diabetologia. 2013;56:423–433. doi: 10.1007/s00125-012-2776-x. PubMed DOI PMC

Pfeiffer A.F.H., Keyhani-Nejad F. High Glycemic Index Metabolic Damage—A Pivotal Role of GIP and GLP-1. Trends Endocrinol. Metab. 2018;29:289–299. doi: 10.1016/j.tem.2018.03.003. PubMed DOI

Malin S.K., Kullman E.L., Scelsi A.R., Godin J.-P., Ross A.B., Kirwan J.P. A Whole-Grain Diet Increases Glucose-Stimulated Insulin Secretion Independent of Gut Hormones in Adults at Risk for Type 2 Diabetes. Mol. Nutr. Food Res. 2019:e1800967. doi: 10.1002/mnfr.201800967. PubMed DOI PMC

Chang C.-Y., Kanthimathi M.S., Tan A.T.-B., Nesaretnam K., Teng K.-T. The amount and types of fatty acids acutely affect insulin, glycemic and gastrointestinal peptide responses but not satiety in metabolic syndrome subjects. Eur. J. Nutr. 2018;57:179–190. doi: 10.1007/s00394-016-1307-9. PubMed DOI

Chalvon-Demersay T., Azzout-Marniche D., Arfsten J., Egli L., Gaudichon C., Karagounis L.G., Tomé D. A Systematic Review of the Effects of Plant Compared with Animal Protein Sources on Features of Metabolic Syndrome. J. Nutr. 2017;147:281–292. doi: 10.3945/jn.116.239574. PubMed DOI

Viguiliouk E., Stewart S.E., Jayalath V.H., Ng A.P., Mirrahimi A., de Souza R.J., Hanley A.J., Bazinet R.P., Blanco Mejia S., Leiter L.A., et al. Effect of Replacing Animal Protein with Plant Protein on Glycemic Control in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2015;7:9804–9824. doi: 10.3390/nu7125509. PubMed DOI PMC

Yu K., Ke M.-Y., Li W.-H., Zhang S.-Q., Fang X.-C. The impact of soluble dietary fibre on gastric emptying, postprandial blood glucose and insulin in patients with type 2 diabetes. Asia Pac. J. Clin. Nutr. 2014;23:210–218. PubMed

Post R.E., Mainous A.G., King D.E., Simpson K.N. Dietary fiber for the treatment of type 2 diabetes mellitus: A meta-analysis. J. Am. Board Fam. Med. 2012;25:16–23. doi: 10.3122/jabfm.2012.01.110148. PubMed DOI

Fukunaka A., Fujitani Y. Role of Zinc Homeostasis in the Pathogenesis of Diabetes and Obesity. Int. J. Mol. Sci. 2018;19:476. doi: 10.3390/ijms19020476. PubMed DOI PMC

Domínguez Avila J.A., Rodrigo García J., González Aguilar G.A., de la Rosa L.A. The Antidiabetic Mechanisms of Polyphenols Related to Increased Glucagon-Like Peptide-1 (GLP1) and Insulin Signaling. Molecules. 2017;22:903. doi: 10.3390/molecules22060903. PubMed DOI PMC

McClean P.L., Irwin N., Cassidy R.S., Holst J.J., Gault V.A., Flatt P.R. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. Am. J. Physiol. Endocrinol. Metab. 2007;293:E1746–E1755. doi: 10.1152/ajpendo.00460.2007. PubMed DOI

Gupta D., Peshavaria M., Monga N., Jetton T.L., Leahy J.L. Physiologic and pharmacologic modulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta-cells by peroxisome proliferator-activated receptor (PPAR)-gamma signaling: Possible mechanism for the GIP resistance in type 2 diabetes. Diabetes. 2010;59:1445–1450. PubMed PMC

Jirapinyo P., Haas A.V., Thompson C.C. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes. Diabetes Care. 2018;41:1106–1115. doi: 10.2337/dc17-1985. PubMed DOI

Davies M.J., D’Alessio D.A., Fradkin J., Kernan W.N., Mathieu C., Mingrone G., Rossing P., Tsapas A., Wexler D.J., Buse J.B. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care. 2018;41:2669–2701. doi: 10.2337/dci18-0033. PubMed DOI PMC

Zander M., Madsbad S., Madsen J.L., Holst J.J. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: A parallel-group study. Lancet. 2002;359:824–830. doi: 10.1016/S0140-6736(02)07952-7. PubMed DOI

Lutz T.A. Amylinergic control of food intake. Physiol. Behav. 2006;89:465–471. doi: 10.1016/j.physbeh.2006.04.001. PubMed DOI

Young A. Inhibition of food intake. Adv. Pharmacol. 2005;52:79–98. PubMed

Kondo Y., Goto A., Noma H., Iso H., Hayashi K., Noda M. Effects of Coffee and Tea Consumption on Glucose Metabolism: A Systematic Review and Network Meta-Analysis. Nutrients. 2018;11:48. doi: 10.3390/nu11010048. PubMed DOI PMC